Stock comparison
Eli Lilly
Stryker
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
SYK
Stryker
Market cap
$121.8B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | SYK | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 65B | LLY |
| Benjamin Graham | 86A | 83A | LLY |
| Philip Fisher | 86A | 67C | LLY |
| Peter Lynch | 74B | 68B | LLY |
| Joel Greenblatt | 78C | 50D | LLY |
| Charlie Munger | 85A | 63D | LLY |
| Terry Smith | 77C | 62D | LLY |
Side-by-side metrics
| Metric | LLY | SYK |
|---|---|---|
| Market cap | $1T | $121.8B |
| P/E (TTM) | 36.6x | 35.2x |
| EV/EBIT | 34.1x | 26.4x |
| ROIC (TTM) | 32.06% | 9.79% |
| Gross margin | 83.51% | 63.67% |
| Net margin | 34.98% | 13.21% |
| Revenue CAGR 5y | 23.17% | 10.07% |
| EPS CAGR 5y | 40.81% | 12.55% |
| Debt / Equity | 1.4x | 0.6x |
| Dividend yield | 0.62% | 1.12% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Market cap$1Tvs $121.8B+88%
- ROIC (TTM)32.06%vs 9.79%+69%
- EPS CAGR 5y40.81%vs 12.55%+69%
- Net margin34.98%vs 13.21%+62%
SYK leads on
- Debt / Equity0.6xvs 1.4x+54%
- Dividend yield1.12%vs 0.62%+44%
- EV/EBIT26.4xvs 34.1x+23%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.